Examining the UK Covid-19 mortality paradox: Pandemic preparedness, healthcare expenditure, and the nursing workforce

J Adv Nurs. 2020 Dec;76(12):3218-3227. doi: 10.1111/jan.14562. Epub 2020 Oct 10.

Abstract

Aim: To examine the UK pandemic preparedness in light of health expenditure, nursing workforce, and mortality rates in and relation to nursing leadership.

Background: The Global Health Security Index categorized the preparedness of 195 countries to face a biological threat on a variety of measures, producing an overall score. The United States of America and the United Kingdom were ranked 1st and 2nd most prepared in 2019.

Method: A cross-nation comparison of the top 36 countries ranked by Global Health Security Index score using a variety of online sources, including key data about each nation's expenditure on health and the nursing workforce, and compared these with mortality data for COVID-19.

Results: The extent of a country's pandemic preparedness, expenditure on healthcare and magnitude of the nursing workforce does not appear to impact mortality rates at this stage of the pandemic which is something of a paradox.

Conclusion: It is important that arrangements for dealing with future global pandemics involve a range of agencies and experts in the field, including nurse leaders.

Implications for nursing: To achieve the best outcomes for patients, nurse leaders should be involved in policy forums at all levels of government to ensure nurses can influence health policy.

Keywords: COVID-19; Global Health Security Index; healthcare expenditure; nurse leadership; nursing workforce; pandemic preparedness.

Publication types

  • Editorial

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / mortality*
  • Coronavirus Infections / virology
  • Health Expenditures*
  • Humans
  • Nursing Staff*
  • Pandemics*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / mortality*
  • Pneumonia, Viral / virology
  • SARS-CoV-2
  • United Kingdom / epidemiology
  • Workforce*